首页> 外国专利> GENE DETECTION ASSAY FOR IMPROVING LIKELIHOOD OF EFFECTIVE RESPONSE TO ERBB ANTAGONIST CANCER THERAPY

GENE DETECTION ASSAY FOR IMPROVING LIKELIHOOD OF EFFECTIVE RESPONSE TO ERBB ANTAGONIST CANCER THERAPY

机译:基因检测评估可改善对ERBB拮抗剂治疗的有效反应

摘要

PROBLEM TO BE SOLVED: To provide a method for more effective treatment of patients susceptible to or diagnosed with tumors overexpressing ErbB, e.g., determined by a gene amplification assay, with an ErbB antagonist.;SOLUTION: A method for increasing the likelihood of effectiveness of an ErbB antagonist cancer treatment comprises administering a cancer-treating dose of the ErbB antagonist to a subject, where an erbB gene in tumor cells in a tissue sample from the subject has been found to be amplified. The ErbB antagonist includes an anti-HER2 antibody. The method further comprises additionally administering a chemotherapeutic agent such as a taxoid.;SELECTED DRAWING: None;COPYRIGHT: (C)2020,JPO&INPIT
机译:要解决的问题:提供一种方法,用ErbB拮抗剂更有效地治疗易感或诊断为过度表达ErbB的患者,例如通过基因扩增测定确定的方法。 ErbB拮抗剂癌症治疗包括对受试者施用癌症治疗剂量的ErbB拮抗剂,其中已经发现来自受试者的组织样品中肿瘤细胞中的erbB基因被扩增。 ErbB拮抗剂包括抗HER2抗体。所述方法还包括另外施用化学治疗剂,例如紫杉烷。

著录项

  • 公开/公告号JP2020023495A

    专利类型

  • 公开/公告日2020-02-13

    原文格式PDF

  • 申请/专利权人 GENENTECH INC;

    申请/专利号JP20190166834

  • 发明设计人 MASS ROBERT D;

    申请日2019-09-13

  • 分类号A61K45;A61P35;A61P15/14;A61K45/06;A61P43;A61P35/02;A61K31/337;A61K39/395;A61K48;C12Q1/6886;C12Q1/6844;

  • 国家 JP

  • 入库时间 2022-08-21 11:36:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号